Nanoadsorbents in focus for the remediation of environmentally-related contaminants with rising toxicity concerns.

Modern lifestyle demands high-end commodities, for instance, cosmetics, detergents, shampoos, household cleaning, sanitary items, medicines, and so forth. In recent years, these products' consumption has increased considerably, being antibiotics and some other pharmaceutical and personal care products (PPCPs). Several antibiotics and PPCPs represent a wide range of emerging contaminants with a straight ingress into aquatic systems, given their high persistence in seawater, effluent treatment plants, and even drinking water. Under these considerations, the necessity of developing new and affordable technologies for the treatment and sustainable mitigation of pollutants is highly requisite for a safer and cleaner environment. One possible mitigation solution is an effective deployment of nanotechnological cues as promising matrices that can contribute by attending issues and improving the current strategies to detect, prevent, and mitigate hazardous pollutants in water. Focused on nanoparticles' distinctive physical and chemical properties, such as high surface area, small size, and shape, metallic nanoparticles (MNPs) have been investigated for water remediation. MNPs gained increasing interest among research groups due to their superior efficiency, stability, and high catalyst activity compared with conventional systems. This review summarizes the occurrence of antibiotics and PPCPs and the application of MNPs as pollutant mitigators in the aquatic environment. The work also focuses on transportation fate, toxicity, and current regulations for environmental safety.

Insight Into Nanoliposomes as Smart Nanocarriers for Greening the Twenty-First Century Biomedical Settings.

The necessity to develop more efficient, biocompatible, patient compliance, and safer treatments in biomedical settings is receiving special attention using nanotechnology as a potential platform to design new drug delivery systems (DDS). Despite the broad range of nanocarrier systems in drug delivery, lack of biocompatibility, poor penetration, low entrapment efficiency, and toxicity are significant challenges that remain to address. Such practices are even more demanding when bioactive agents are intended to be loaded on a nanocarrier system, especially for topical treatment purposes. For the aforesaid reasons, the search for more efficient nano-vesicular systems, such as nanoliposomes, with a high biocompatibility index and controlled releases has increased considerably in the past few decades. Owing to the stratum corneum layer barrier of the skin, the in-practice conventional/conformist drug delivery methods are inefficient, and the effect of the administered therapeutic cues is limited. The current advancement at the nanoscale has transformed the drug delivery sector. Nanoliposomes, as robust nanocarriers, are becoming popular for biomedical applications because of safety, patient compliance, and quick action. Herein, we reviewed state-of-the-art nanoliposomes as a smart and sophisticated drug delivery approach. Following a brief introduction, the drug delivery mechanism of nanoliposomes is discussed with suitable examples for the treatment of numerous diseases with a brief emphasis on fungal infections. The latter half of the work is focused on the applied perspective and clinical translation of nanoliposomes. Furthermore, a detailed overview of clinical applications and future perspectives has been included in this review.